Analysis

Perturbation Study of Dissolution Apparatus Variables—A Design of Experiment Approach

Abstract
The specifications and acceptable ranges for nine critical dissolution apparatus variables were examined during a perturbation
study of USP dissolution Apparatus 2 using USP Prednisone Reference Standard (RS) Tablets. A Design of Experiment
(1) approach was used to screen the nine variables to determine the contribution of each, alone and in combination,

Author(s): 
Joseph Eaton,Gang Deng,Walter W. Hauck, William Brown, Ronald G. Manning, and Samir Wahab
Journal: 
dissolutiontechnologies

In Vitro–In Vivo Correlation: Importance of Dissolution in IVIVC

Introduction
Correlations between in vitro and in vivo data (IVIVC)
are often used during pharmaceutical development in
order to reduce development time and optimize the
formulation. A good correlation is a tool for predicting in
vivo results based on in vitro data. IVIVC allows dosage form
optimization with the fewest possible trials in man, fixes

Author(s): 
J-M. Cardot, E. Beyssac, and M.Alric
Journal: 
.dissolutiontechnologiesFebruary 2007 Volume 14 Issue 1

Vibration Measurements on Dissolution Systems and Effects on Dissolution of Prednisone Tablets RS

Abstract
Efforts are being made by various groups (1,2) to focus more on mechanical calibration as a potential replacement for Prednisone
tablets RS (calibrator tablets). Although some mechanical calibration is currently performed (e.g.,wobble,centering),
the PhRMA committee’s original proposal was to replace the Prednisone tablets RS through use of enhanced mechanical calibration.

Author(s): 
Saroj Vangani,Tawnya Flick,Germinia Tamayo, Rick Chiu, and Nina Cauchon
Journal: 
dissolutiontechnologiesFebruary 2007 Volume 14 Issue 1

Question & Answer Section

Question and Answer Section - August 2008

William Brown and Margareth Marques
The following questions have been submitted by readers of Dissolution Technologies. Margareth Marques, Ph. D. and Will Brown, United States Phamacopeia, authored responses to each of the questions.

Author(s): 
Margareth Marques and William Brown
Journal: 
dissolutiontechnologics,August 2008 Volume 15 Issue 3

Meeting Report: AAPS Workshop on the Role of Dissolution in QbD and Drug Product Life Cycle

Aworkshop on the Role of Dissolution in QbD and
Drug Product Life Cycle was held in Crystal City,
Virginia. This workshop was jointly sponsored by
U.S. Food and Drug Administration and AAPS. The
meeting audio tapes are available at http://www.
aapspharmaceutica.com/meetings/meeting.asp?id=126.
The theme of the entire workshop was the exploration

Author(s): 
Kailas Thakker1 and Vivian Gray2
Journal: 
Dissolution Technologies ,August 2008 Volume 15 Issue 3

Dissolution Stability Study of Cefadroxil Extemporaneous Suspensions

Dissolution studies have become matter of great significance because, in most cases, drug dissolution is the
rate-limiting step in the absorption process. As occurs with solid oral dosage forms, heterogeneous disperse systems
(suspensions) could also have some problems with their in vitro dissolution.

Author(s): 
Noelia L. Gonzalez Vidal1,2,3, Patricia D. Zubata1, Laura D. Simionato1, and Maria T. Pizzorno1, 2
Journal: 
Dissolution Technologies August 2008 Volume 15 Issue 3

Physicochemical Characterization and Dissolution Study of Solid Dispersions of Furosemide with Polyethylene Glycol 6000 and Poly

ABSTRACT
Solid dispersions traditionally have been used as effective methods to improve the dissolution properties and
bioavailability of poorly water-soluble drugs. The aim of the present study was to improve the solubility and dissolution
rate of a poorly water-soluble drug, furosemide, by a solid dispersion technique. Solid dispersions were prepared using

Author(s): 
Rakesh P. Patel, Dhaval J. Patel, Dipen B. Bhimani, and Jayvadan K. Patel
Journal: 
Dissolution Technologies, August 2008 Volume 15 Issue 3

New Dissolution Method for Mesalamine Tablets and Capsules

ABSTRACT
Dissolution methods are different for extended-release mesalamine capsules (pH 7.5 only) and delayed-release tablets
(pH 1.4, 6.0, and 7.2). Mesalamine is used for the treatment of ulcerative colitis. The USP methods have several drawbacks
in that they do not mimic gastrointestinal tract environments; tablets are removed from vessels to change dissolution

Author(s): 
Monica C. Chuong1, J. Mark Christensen2, and James W. Ayres2
Journal: 
Dissolution Technologies, August 2008 Volume 15 Issue 3

Question & Answer Section

Question and Answer Section - May 2008

William Brown and Margareth Marques
The following questions have been submitted by readers of Dissolution Technologies. Margareth Marques, Ph. D. and Will Brown, United States Phamacopeia, authored responses to each of the questions.
*Note: These are opinions and interpretations of the authors, and are not necessarily the official viewpoints of the USP

Author(s): 
Margareth Marques and William Brown
Journal: 
dissolutiontechnologics, May 2008 Volume 15 Issue 2

Development of Discriminating Method for Dissolution of Aceclofenac Marketed Formulations

ABSTRACT
The development of a meaningful dissolution procedure for drug products with limited water solubility has been a
challenge to the pharmaceutical industry. Aceclofenac (BCS Class II drug) is a nonsteroidal anti-inflammatory drug. There
is no official dissolution medium available in the literature. In the present study, parameters such as solubility, medium pH,

Author(s): 
Tejal Soni1,4, Chirag Nagda2,Tejal Gandhi2, and N. P. Chotai3
Journal: 
Dissolution Technologies May 2008 Volume 15 Issue 2
Syndicate content